NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIMH E-281-1999-0-US-03 Tyrosine-DNA Phosphodiestrerases(TDP) and Related Polypeptides, Nucleic Acids, Vectors, TDP-Producing Host Cells, Antibodies and Methods of Use US National Stage 10/110,176 7087736 Abandoned PDF
NCI E-194-1998-0-US-03 Calcium Channel Proteins US DIV 10/116,949 6979724 Abandoned PDF
NCI E-057-2002-1-US-01 Conjugates of Ligand, Linker and Cytotoxic Agents and Related Composition And Methods of Use US 60/370,189 Abandoned
NHLBI E-148-2001-0-US-01 METHOD AND APPARATUS FOR COUNTERCURRENT CHROMATOGRAPHY US 60/370,641 Abandoned
NCI E-060-2002-1-US-01 DNA Binding Polyamide Drug Conjugates US 60/370,168 Abandoned
NCI E-125-2002-0-US-01 METHODS OF DIAGNOSING PROTENTIAL FOR DEVELOPING HEPATOCELLULAR CARCINOMA OR METASTASIS AND IDENTIFYING THERAPEUTIC TARGETS US 60/370,895 Abandoned
NCI E-199-2002-0-US-01 Treatment Method of Kidney Cancer US 60/369,868 Abandoned
NCI E-090-2001-0-ZA-07 Retroviral Protease Inhibiting Compound and Methods of Preparation, Pharmaceutical Compositions and Methods of Treating Viral Infections ZA National Stage ZA 200202655 Expired
NCI E-172-2000-0-PCT-02 Nucleic Acids For Transgene Expression PCT PCT PCT/US02/10594 Abandoned
NCI E-138-2001-0-PCT-02 Use of Semenogelin in the Diagnosis, Prognosis And Treatment of Cancer PCT PCT PCT/US02/10535 Expired
NICHD E-069-2000-3-CA-01 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... CA National Stage 2412864 Abandoned
NICHD E-069-2000-3-DE-09 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... DE EP 02728620.2 Abandoned
NICHD E-069-2000-3-FR-10 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... FR EP 02728620.2 Abandoned
NICHD E-069-2000-3-SE-17 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... SE EP 02728620.2 Abandoned
NICHD E-069-2000-3-CH-08 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... CH EP 02728620.2 Abandoned
NICHD E-069-2000-3-ES-14 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... ES EP 02728620.2 Abandoned
NICHD E-069-2000-3-NL-16 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... NL EP 02728620.2 Abandoned
NICHD E-069-2000-3-LU-15 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... LU EP 02728620.2 Abandoned
NICHD E-069-2000-3-GB-11 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... GB EP 02728620.2 Abandoned
NICHD E-069-2000-3-BE-07 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... BE EP 02728620.2 Abandoned
NICHD E-069-2000-3-AT-06 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... AT EP 02728620.2 Abandoned
NICHD E-069-2000-3-EP-03 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... EP National Stage 02728620.2 Abandoned
NICHD E-069-2000-3-DK-13 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... DK EP 02728620.2 Abandoned
NICHD E-069-2000-3-IT-12 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... IT EP 02728620.2 Abandoned
NICHD E-069-2000-3-AU-02 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... AU National Stage 2002258664 Abandoned
NIAID E-328-2000-0-PCT-02 Plasmodium Falciparum Erythrocyte Binding Protein Baebl For Use as a Vaccine PCT PCT PCT/US02/10071 Expired
NICHD E-069-2000-3-PCT-01 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... PCT PCT COMB PCT/US2002/009886 Expired
NICHD E-239-2000-1-PCT-01 Human Gene Critical To Fertility PCT PCT COMB PCT/US2002/009776 Expired
NICHD E-069-2000-3-JP-04 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... JP National Stage 2003-546900 Abandoned
NICHD E-239-2000-1-EP-05 Human Gene Critical To Fertility EP National Stage 02723673.6 Abandoned
NICHD E-239-2000-1-AU-03 Human Gene Critical To Fertility AU National Stage 2002254442 Abandoned
NICHD E-239-2000-1-CA-04 Human Gene Critical To Fertility CA National Stage 2443341 Abandoned
NICHD E-089-2001-0-EP-05 USE OF HEPRPESVIRUSES, PROTEINS AND NUCLEIC ACIDS ENCODING THE PROTIENS TO INHIBIT CCR5-TROPIC HIV-1 INFECTION AND REPLICATION EP National Stage 02731205.7 Abandoned
NCI E-050-2000-0-CA-12 Geldanamycin Derivative And Method of Treating Cancer Using Same CA National Stage 2430692 Expired
NCI E-050-2000-0-IL-11 Geldanamycin Derivative And Method of Treating Cancer Using Same IL National Stage 156122 Expired
NCI E-050-2000-0-IN-06 Geldanamycin Derivative And Method of Treating Cancer Using Same IN National Stage 1073/DELNP/2003 Expired
NCI E-050-2000-0-JP-05 Geldanamycin Derivative And Method of Treating Cancer Using Same JP National Stage 2002-577794 Expired
NCI E-050-2000-0-KR-09 Geldanamycin Derivative And Method of Treating Cancer Using Same KR National Stage 10-2003-7008551 Expired
NCI E-050-2000-0-AU-04 Geldanamycin Derivative And Method of Treating Cancer Using Same AU National Stage 2002307020 Expired
NCI E-050-2000-0-MX-10 Geldanamycin Derivative And Method of Treating Cancer Using Same MX National Stage PA/a/2003/007856 Expired
NCI E-050-2000-0-NL-32 Geldanamycin Derivative and Method of Treating Cancer Using Same NL EP 02757908.5 Expired
NCI E-050-2000-0-LI-29 Geldanamycin Derivative and Method of Treating Cancer Using Same LI EP 02757908.5 Expired
NCI E-050-2000-0-MC-31 Geldanamycin Derivative and Method of Treating Cancer Using Same MC EP 02757908.5 Expired
NCI E-050-2000-0-LU-30 Geldanamycin Derivative and Method of Treating Cancer Using Same LU EP 02757908.5 Expired
NCI E-050-2000-0-BE-17 Geldanamycin Derivative and Method of Treating Cancer Using Same BE EP 02757908.5 Expired
NCI E-050-2000-0-AT-16 Geldanamycin Derivative and Method of Treating Cancer Using Same AT EP 02757908.5 Expired
NCI E-050-2000-0-CY-19 Geldanamycin Derivative and Method of Treating Cancer Using Same CY EP 02757908.5 Expired
NCI E-050-2000-0-FI-23 Geldanamycin Derivative and Method of Treating Cancer Using Same FI EP 02757908.5 Expired
NCI E-050-2000-0-DK-21 Geldanamycin Derivative and Method of Treating Cancer Using Same DK EP 02757908.5 Expired
NCI E-050-2000-0-FR-24 Geldanamycin Derivative and Method of Treating Cancer Using Same FR EP 02757908.5 Expired